HCA vs LMRI
HCA: HCA Healthcare is one of the nation's largest operators of acute care hospitals and related health services, leveraging a massive footprint to provide comprehensive medical care. LMRI: Lumexa is a leading national provider of outpatient diagnostic imaging services and radiologist interpretation with 188 imaging centers across 13 states, generating revenue from patient imaging, radiologist services, and management fees.
Side-by-side fundamentals
| Metric | HCA | LMRI | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $389.62 | $11.05 | |
| Market cap as of 2026-07-29 | $90.9B | $1.1B | |
| P/E as of 2026-07-29 | 13.40 | n/a | |
| PEG as of 2026-07-29 | 1.31 | n/a | |
| Net margin as of 2026-07-29 | +8.9% | -3.6% | HCA higher |
| Gross margin as of 2026-07-29 | +85.0% | +15.1% | HCA higher |
| Operating margin as of 2026-07-29 | +15.7% | +8.1% | HCA higher |
| ROE as of 2026-07-29 | +695.7% | -8.0% | HCA higher |
| ROA as of 2026-07-29 | +11.3% | -2.7% | HCA higher |
| Debt / equity as of 2026-07-29 | 125.80 | 1.47 | LMRI lower |
| Revenue growth (YoY) as of 2026-07-29 | +6.7% | +8.0% | LMRI higher |
| Revenue CAGR (3y) SEC XBRL | +7.9% | n/a | |
| Dividend yield as of 2026-07-29 | +0.7% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-29 | 1.10 | 1.02 | |
| 1-year return as of 2026-07-27 close | +16.5% | n/a |
Fundamentals: Finnhub, as of 2026-07-29. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.